Eprotirome
CAS: 355129-15-6
Rif. 3D-FPA12915
| 1mg | Prezzo su richiesta | |
| 5mg | Prezzo su richiesta | |
| 10mg | Prezzo su richiesta | |
| 25mg | Prezzo su richiesta | |
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
- 3-((3,5-Dibromo-4-(4-hydroxy-3-isopropylphenoxy)phenyl)amino)-3-oxopropanoic acid
- 3-[3,5-Dibromo-4-(4-hydroxy-3-isopropylphenoxy)anilino]-3-oxo-propanoic acid
- 3-[[3,5-Dibromo-4-[4-hydroxy-3-(1-methylethyl)phenoxy]phenyl]amino]-3-oxopropanoic acid
- Kb 2115
- N-[3,5-Dibromo-4-(4-hydroxy-3-isopropylphenoxy)phenyl]malonamic acid
- Propanoic acid, 3-[[3,5-dibromo-4-[4-hydroxy-3-(1-methylethyl)phenoxy]phenyl]amino]-3-oxo-
Eprotirome is a thyroid hormone receptor agonist that is used to treat patients with hepatic steatosis and congestive heart failure. Eprotirome has been shown to increase the rate of metabolism, decrease LDL cholesterol, and reduce the risk of atherosclerotic cardiovascular disease. Eprotirome binds to TRs on the cell surface, which increases intracellular cyclic AMP levels by stimulating adenylyl cyclase. This increases the level of active thyroid hormone in the body and leads to a number of effects including increased energy metabolism, decreased LDL cholesterol, reduced cardiac effects, and increased ldl-c lowering.
Proprietà chimiche
Richiesta tecnica su: 3D-FPA12915 Eprotirome
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
